Inhibikase Therapeutics, Inc. (IKT) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 172.18M | 180.11M | 78.54M | 88.79M | 94.16M | 98.45M | 4.19M | 8.6M | 10.81M | 14.21M | 17.55M | 21.98M | 27.63M | 24.37M | 27.99M | 33.95M | 38.39M | 42.47M | 45.87M | 49.22M |
| Cash & Short-Term Investments | 170.37M | 178.76M | 77.32M | 87.67M | 93.18M | 97.54M | 3.24M | 7.94M | 9.75M | 13.25M | 16.83M | 20.94M | 25.72M | 23.05M | 26.53M | 32.21M | 36.61M | 40.75M | 44.85M | 46.84M |
| Cash Only | 49.57M | 139.22M | 38.27M | 77.74M | 73.44M | 56.49M | 913.42K | 3.09M | 2.35M | 9.17M | 14.86M | 1.91M | 3.96M | 7.19M | 5.78M | 32.21M | 36.61M | 40.75M | 44.85M | 46.84M |
| Short-Term Investments | 120.8M | 39.54M | 39.05M | 9.92M | 19.74M | 41.05M | 2.33M | 4.85M | 7.4M | 4.09M | 1.97M | 19.03M | 21.76M | 15.86M | 20.75M | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 79.6K | 64.52K | 39.88K | 13.84K | 6.55K | 47.98K | 110.14K | 217.48K | 586.58K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | 56.33 | 72.82 | 38.88 | 128.67 | 378.67 | 154.58 | 7.75K | 112.61 | 30.69 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 958.78K |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31.92 |
| Other Current Assets | 1.81M | 1.35M | 620.63K | 471.23K | 77.47K | 106.31K | 690.54K | 331.3K | 851.06K | 244.82K | 372.56K | 450.23K | 948.13K | 1.12M | 957.42K | 944.05K | 565.3K | 107K | 0 | 833.96K |
| Total Non-Current Assets | 1.16M | 1.1M | 1.06M | 58.6K | 116.56K | 148.54K | 186.77K | 224K | 260.26K | 295.6K | 330.03K | 363.62K | 534.75K | 565.17K | 594.82K | 43.09K | 0 | 0 | 0 | 0 |
| Property, Plant & Equipment | 0 | 0 | 0 | 58.6K | 116.56K | 148.54K | 186.77K | 224K | 260.26K | 295.6K | 330.03K | 363.62K | 534.75K | 565.17K | 594.82K | 43.09K | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | 0.00x | 0.23x | 0.26x | 0.12x | 0.11x | 0.02x | 0.15x | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.16M | 1.1M | 1.06M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 173.33M | 181.2M | 79.59M | 88.85M | 94.28M | 98.6M | 4.38M | 8.83M | 11.07M | 14.51M | 17.88M | 22.35M | 28.16M | 24.94M | 28.58M | 33.99M | 38.39M | 42.47M | 45.87M | 49.22M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.04x |
| Asset Growth % | 83.85% | 83.78% | 1718.52% | 906.63% | 751.83% | 579.69% | -75.52% | -60.5% | -60.7% | -41.83% | -37.44% | -34.26% | -26.64% | -41.28% | -37.69% | -30.93% | 223.31% | 187.3% | 3032.69% | 13323.53% |
| Total Current Liabilities | 5.71M | 8.3M | 6.7M | 8.8M | 8.55M | 3.73M | 4.91M | 3.7M | 4.23M | 3.44M | 2.74M | 2.73M | 2.66M | 3.7M | 3.21M | 4.49M | 4.38M | 4.05M | 2.71M | 1.91M |
| Accounts Payable | 1.59M | 1.16M | 620.53K | 2.7M | 1.69M | 943.02K | 2.53M | 1.34M | 1.29M | 646.77K | 734.56K | 754.15K | 959.08K | 1.15M | 781.22K | 860.44K | 806.2K | 1.09M | 553.8K | 897.23K |
| Days Payables Outstanding | - | - | - | - | - | 24.32K | 27.1K | 18.25K | 13.44K | 9.67K | 10.43K | 489.63 | 18.83K | 17.63K | 44.92K | 25.43 | 28.28 | 22.3 | 21.16 | 30.79 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 71.66K | 177.26K | 280.61K | 381.78K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 248.91K | 248.91K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 142.62K |
| Other Current Liabilities | 4.12M | 7.14M | 2.42M | 2.91M | 3.27M | 0 | 0 | 0 | 325.06K | 1.62M | 0 | 0 | 0 | 0 | 23.68K | 23.68K | 0 | 0 | 0 | 0 |
| Current Ratio | 30.14x | 21.70x | 11.73x | 10.09x | 11.01x | 26.37x | 0.85x | 2.32x | 2.55x | 4.13x | 6.40x | 8.04x | 10.37x | 6.59x | 8.71x | 7.56x | 8.76x | 10.47x | 16.94x | 25.73x |
| Quick Ratio | 30.14x | 21.70x | 11.73x | 10.09x | 11.01x | 26.37x | 0.85x | 2.32x | 2.55x | 4.13x | 6.40x | 8.04x | 10.37x | 6.59x | 8.71x | 7.56x | 8.76x | 10.47x | 16.94x | 25.23x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31.82 |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.61K | 58.33K | 90.12K | 121.01K | 149.97K | 178.11K | 205.45K | 232.02K | 0 | 0 | 0 | 0 | 248.91K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 248.91K |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.61K | 58.33K | 90.12K | 121.01K | 149.97K | 178.11K | 205.45K | 232.02K | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 5.71M | 8.3M | 6.7M | 8.8M | 8.55M | 3.73M | 4.91M | 3.73M | 4.29M | 3.53M | 2.86M | 2.88M | 2.84M | 3.9M | 3.45M | 4.49M | 4.38M | 4.05M | 2.71M | 2.16M |
| Total Debt | 0 | 0 | 0 | 37.94K | 74.77K | 110.52K | 216.87K | 355.09K | 490.1K | 622K | 270.04K | 297.94K | 325.01K | 351.29K | 374.07K | 0 | 0 | 248.91K | 248.91K | 248.91K |
| Net Debt | -49.57M | -139.22M | -38.27M | -77.7M | -73.37M | -56.38M | -696.55K | -2.73M | -1.86M | -8.54M | -14.59M | -1.61M | -3.63M | -6.84M | -5.41M | -32.21M | -36.61M | -40.5M | -44.6M | -46.59M |
| Debt / Equity | - | - | - | 0.00x | 0.00x | 0.00x | - | 0.07x | 0.07x | 0.06x | 0.02x | 0.02x | 0.01x | 0.02x | 0.01x | - | - | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -928119.20x | -31907.98x | -28477.96x | -336.50x |
| Total Equity | 167.62M | 172.9M | 72.9M | 80.05M | 85.73M | 94.87M | -530.59K | 5.1M | 6.78M | 10.98M | 15.02M | 19.46M | 25.32M | 21.04M | 25.14M | 29.5M | 34.01M | 38.42M | 43.16M | 47.05M |
| Equity Growth % | 95.52% | 82.26% | 13839.08% | 1470.71% | 1165.09% | 764.16% | -103.53% | -73.82% | -73.24% | -47.81% | -40.25% | -34.02% | -25.55% | -45.24% | -41.76% | -37.3% | 323.18% | 292.62% | 942.17% | 1074.08% |
| Book Value per Share | 1.71 | 1.76 | 0.81 | 0.89 | 0.96 | 1.37 | -0.06 | 0.68 | 1.07 | 1.77 | 2.81 | 3.72 | 5.52 | 5.00 | 5.98 | 6.98 | 8.10 | 9.14 | 10.30 | 23.06 |
| Total Shareholders' Equity | 167.62M | 172.9M | 72.9M | 80.05M | 85.73M | 94.87M | -530.59K | 5.1M | 6.78M | 10.98M | 15.02M | 19.46M | 25.32M | 21.04M | 25.14M | 29.5M | 34.01M | 38.42M | 43.16M | 47.05M |
| Common Stock | 132.03K | 131.69K | 74.81K | 74.52K | 74.34K | 69.36K | 7.46K | 7.22K | 6.48K | 6.19K | 5.36K | 5.29K | 31.06K | 4.22K | 25.23K | 25.23K | 25.23K | 25.16K | 25.16K | 25.13K |
| Retained Earnings | -159.06M | -142.68M | -129.94M | -118.01M | -108.1M | -94.42M | -82.29M | -76.51M | -71.55M | -66.9M | -62.72M | -58.13M | -52.35M | -47.87M | -43.59M | -39.1M | -34.46M | -29.82M | -24.78M | -20.3M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -26.29K | 21.8K | -4.19K | -2.94K | -967 | -37.25K | 1.75K | -1.02K | -1.8K | 877 | -143 | -1.71K | 165.82K | 104.72K | 26.83K | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |